Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism
Authors:
- Chikatoshi KatadaCKChikatoshi Katada
- Tetsuji YokoyamaTYTetsuji Yokoyama
- Kanae MureKMKanae Mure
- Hisashi DoyamaHDHisashi Doyama
- Hiroyoshi NakanishiHNHiroyoshi Nakanishi
- Yuichi ShimizuYSYuichi Shimizu
- Keiko YamamotoKYKeiko Yamamoto
- Yasuaki FurueYFYasuaki Furue
- Masashi TamaokiMTMasashi Tamaoki
- Tomoyuki KoikeTomoyuki Koike
- Yoshiro KawaharaYKYoshiro Kawahara
- Hirofumi KiyokawaHKHirofumi Kiyokawa
- 27 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 53 (9) , 774-780
Abstract
Multiple development of esophageal squamous-cell carcinoma is explained by field cancerization and is associated with alcohol consumption and smoking. We investigated the association between the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma and genetic polymorphisms related to alcohol and nicotine metabolism. The study group comprised 56 patients with esophageal squamous-cell carcinoma after endoscopic resection. The main variables were the following: (i) cumulative incidence and total number of second primary esophageal squamous-cell carcinoma according to genetic polymorphisms in alcohol dehydrogenase 1B, aldehyde dehydrogenase 2 and cytochrome P450 2A6; and (ii) risk factors of second primary esophageal squamous-cell carcinoma identified using a multivariate Cox proportional-hazards model. The frequencies of alcohol dehydrogenase 1B, aldehyde dehydrogenase 2 and cytochrome P450 2A6 genetic polymorphisms in the buccal mucosa were analyzed. The median follow-up was 92.8 months (range: 2.7–134.2). Slow-metabolizing alcohol dehydrogenase 1B was associated with a higher 7-year cumulative incidence of second primary esophageal squamous-cell carcinoma (fast-metabolizing alcohol dehydrogenase 1B vs slow-metabolizing alcohol dehydrogenase 1B: 20.5% vs 71.4%, P = 0.006). Slow-metabolizing alcohol dehydrogenase 1B (relative risk [95% confidence interval]: 3.17 [1.49–6.73]), inactive aldehyde dehydrogenase 2 (2.17 [1.01–4.63]) and poorly-metabolizing cytochrome P450 2A6 (4.63 [1.74–12.33]) had a significantly higher total number of second primary esophageal squamous-cell carcinoma per 100 person-years. In the multivariate Cox proportional-hazards model, slow-metabolizing alcohol dehydrogenase 1B was a significant risk factor of the development of second primary esophageal squamous-cell carcinoma (hazard ratio 9.92, 95% confidence interval: 2.35–41.98, P = 0.0018). Slow-metabolizing alcohol dehydrogenase 1B may be a significant risk factor for the development of second primary esophageal squamous-cell carcinoma. In addition, inactive aldehyde dehydrogenase 2 and poorly-metabolizing cytochrome P450 2A6 may be important factors.Keywords
Funding Information
- Ministry of Health, Labour and Welfare, Japan
- National Cancer Center Research and Development Fund 36
- JSPS (JP17K09093)
This publication has 30 references indexed in Scilit:
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology ConsortiumCancer Epidemiology, Biomarkers & Prevention, 2009
- Geographically Separate Increases in the Frequency of the Derived ADH1B*47His Allele in Eastern and Western AsiaThe American Journal of Human Genetics, 2007
- The Role ofCYP2A6in the Emergence of Nicotine Dependence in AdolescentsPediatrics, 2007
- Epidemiology and Pathogenesis of Esophageal CancerSeminars in Radiation Oncology, 2007
- When risk factors combine: The interaction between alcohol and smoking for aerodigestive cancer, coronary heart disease, and traffic and fire injuryAddictive Behaviors, 2006
- Esophageal Squamous Cell Carcinoma and Aldehyde Dehydrogenase‐2 Genotypes in Japanese FemalesAlcohol, Clinical and Experimental Research, 2006
- Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokersCarcinogenesis, 2004
- Esophageal CancerNew England Journal of Medicine, 2003
- Polymorphisms of CYP2A6 and its practical consequencesBritish Journal of Clinical Pharmacology, 2001
- Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patientsGut, 2000